Mediar Therapeutics Funding: $181M Raised, Series A (2023)
Mediar Therapeutics is based in Boston. It has raised $181M in total funding. Latest round: Series A. Backed by Amplitude Ventures, ICG, Longwood Fund.
Mediar Therapeutics funding overview
Mediar Therapeutics is based in Boston. Mediar Therapeutics has raised $181M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in March 2023. The round record for Mediar Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Amplitude Ventures, ICG, Longwood Fund, Asahi Kasei Pharma Ventures, Alexandria Real Estate Trust, Novartis Venture Fund and 9 others. 15 distinct backers are named across the disclosed rounds.
Frequently asked about Mediar Therapeutics funding
How much has Mediar Therapeutics raised?
Mediar Therapeutics has raised $181M in total disclosed funding across the rounds on record.
Who has invested in Mediar Therapeutics?
Amplitude Ventures, ICG, Longwood Fund, Asahi Kasei Pharma Ventures, Alexandria Real Estate Trust, Novartis Venture Fund are named among the investors backing Mediar Therapeutics.
What was the latest Mediar Therapeutics funding round?
The most recent disclosed round is a Series A, announced in March 2023.
Where is Mediar Therapeutics based?
Mediar Therapeutics is based in Boston.
When did Mediar Therapeutics last raise?
The last disclosed Mediar Therapeutics round closed in March 2023 at Series A.
We update the Mediar Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Boston and their backers are listed below.
